Lv1
60 积分 2024-06-07 加入
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
2个月前
已完结
A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer
3个月前
已完结
Predicting Survival Signature of Bladder Cancer Related to Cancer-Associated Fibroblast (CAF) Constructed by Intersecting Genes in TCGA and GEO
3个月前
已完结
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
4个月前
已完结
Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site
4个月前
已关闭
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
4个月前
已完结
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
6个月前
已完结
Right Ureteral Carcinoma Suggested by 99mTc-DTPA Renography in a Patient With Left Pyelocaliceal Carcinoma
6个月前
已完结
Correction of differential renal function for asymmetric renal area ratio in unilateral hydronephrosis
6个月前
已完结
Contradictory Supranormal Differential Renal Function During Nuclear Renographic Investigation of Hydroureteronephrosis
6个月前
已完结
皖公网安备34019202002308
